Hirsch Andrew

CIK 00015867074 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001586707

Recent Transactions

50 trades

Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2025-06-06+37,500→ 37,500 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2025-02-15$3.18/sh−9,370→ 423,145 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2025-02-14$3.18/sh−12,847→ 432,515 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2025-02-14+335,300→ 335,300 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2025-02-14+223,500→ 445,362 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-11-07+12,500→ 227,412 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-11-07$6.04/sh−5,550→ 221,862 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2024-11-07−12,500→ 35,000 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-09-16$6.36/sh−3,329→ 214,912 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-09-16+7,500→ 218,241 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2024-09-16−7,500→ 47,500 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2024-05-30+25,000→ 25,000 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-02-15$7.90/sh−6,560→ 210,741 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-02-14+103,400→ 217,301 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2024-02-14+465,500→ 465,500 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2023-09-18+489,600→ 489,600 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2023-08-30−7,500→ 55,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-08-30+7,500→ 116,106 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-08-30$2.93/sh−2,205→ 113,901 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2023-06-01+25,000→ 25,000 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2023-02-15+367,200→ 367,200 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-02-15+81,600→ 108,606 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2023-01-30−12,500→ 62,500 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-30+12,500→ 31,325 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-30$7.78/sh−4,319→ 27,006 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2022-06-09+25,000→ 25,000 total
Tax Payment
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-05-26$7.01/sh−3,675→ 18,825 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2022-05-25−12,500→ 75,000 total
Exercise/Conversion
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-05-25+12,500→ 22,500 total
Purchase
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-04-12$8.40/sh+10,000→ 10,000 total
Award
C4 Therapeutics, Inc.$CCCC
Performance Restricted Stock Units
2022-02-23+87,500→ 87,500 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2021-06-03+11,538→ 11,538 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2020-10-01+1,691,672→ 1,691,672 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2020-06-10+11,538→ 11,538 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-04-22$45.91/sh−1,927→ 24,272 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2020-04-22−5,893→ 11,785 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-04-22+5,893→ 26,199 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-04-14$40.64/sh−1,599→ 20,306 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-04-13+5,387→ 21,905 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2020-04-13−5,387→ 10,775 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-02-24$48.66/sh−1,056→ 16,518 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-02-22+3,333→ 17,574 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2020-02-22−3,333→ 6,667 total
Tax Payment
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-02-18$52.01/sh−886→ 14,241 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2020-02-16+2,750→ 15,127 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2020-02-16−2,750→ 2,750 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock option (right to buy)
2020-02-14+45,000→ 45,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2020-02-14+12,000→ 12,000 total
Award
Editas Medicine, Inc.$EDIT
Stock Option (right to buy)
2019-06-12+11,538→ 11,538 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2019-04-22+17,678→ 17,678 total

Companies

Recent Filings

Address

C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET

CAMBRIDGE, MA, 02139

View on SEC.gov